These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Öberg K; Knigge U; Kwekkeboom D; Perren A; Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445 [No Abstract] [Full Text] [Related]
3. Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties. Kankava K; Maisonneuve P; Mangogna A; Centonze G; Cattaneo L; Prinzi N; Pusceddu S; Fazio N; Pisa E; Di Domenico S; Bertani E; Mazzaferro V; Albertelli M; Grillo F; Milione M J Neuroendocrinol; 2021 Aug; 33(8):e13000. PubMed ID: 34268808 [TBL] [Abstract][Full Text] [Related]
4. Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome. Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598 [TBL] [Abstract][Full Text] [Related]
5. Aberrant Expression of Long Non Coding RNA HOTAIR and De-Regulation of the Paralogous 13 HOX Genes Are Strongly Associated with Aggressive Behavior of Gastro-Entero-Pancreatic Neuroendocrine Tumors. Di Mauro A; Scognamiglio G; Aquino G; Cerrone M; Liguori G; Clemente O; Di Bonito M; Cantile M; Botti G; Tafuto S; Tatangelo F Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208964 [TBL] [Abstract][Full Text] [Related]
6. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs). Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087 [TBL] [Abstract][Full Text] [Related]
7. Gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NENs) - Current literature review of diagnostics and therapy. What has changed in the management? Jurkiewicz K; Miciak M; Kaliszewski K Pol Przegl Chir; 2024 Mar; 96(4):58-66. PubMed ID: 39138986 [TBL] [Abstract][Full Text] [Related]
8. Recent updates on grading and classification of neuroendocrine tumors. Kim JY; Hong SM; Ro JY Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335 [TBL] [Abstract][Full Text] [Related]
9. Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites. Sadowski SM; Neychev V; Millo C; Shih J; Nilubol N; Herscovitch P; Pacak K; Marx SJ; Kebebew E J Clin Oncol; 2016 Feb; 34(6):588-96. PubMed ID: 26712231 [TBL] [Abstract][Full Text] [Related]
11. Aggressive gastro-entero-pancreatic neoplasms. Coriat R Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660 [No Abstract] [Full Text] [Related]
12. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study. Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205 [TBL] [Abstract][Full Text] [Related]
13. [Gastroenteropancreatic neuroendocrine tumors : (GEP-NENs)]. Sebesta C; Feichter A; Selimi F Wien Med Wochenschr; 2023 Jun; 173(9-10):221-226. PubMed ID: 36512264 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms. Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843 [TBL] [Abstract][Full Text] [Related]
16. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors. Chauhan A; Chan K; Halfdanarson TR; Bellizzi AM; Rindi G; O'Toole D; Ge PS; Jain D; Dasari A; Anaya DA; Bergsland E; Mittra E; Wei AC; Hope TA; Kendi AT; Thomas SM; Flem S; Brierley J; Asare EA; Washington K; Shi C CA Cancer J Clin; 2024; 74(4):359-367. PubMed ID: 38685134 [TBL] [Abstract][Full Text] [Related]
17. Pathology - grading and staging of GEP-NETs. Capelli P; Fassan M; Scarpa A Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):705-17. PubMed ID: 23582914 [TBL] [Abstract][Full Text] [Related]
19. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. Masui T; Ito T; Komoto I; Uemoto S; BMC Cancer; 2020 Nov; 20(1):1104. PubMed ID: 33189127 [TBL] [Abstract][Full Text] [Related]
20. Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study. Shi H; Zhang Q; Han C; Zhen D; Lin R BMC Endocr Disord; 2018 Jul; 18(1):51. PubMed ID: 30055596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]